Vanguard, CeNeS seek mass

Consolidation as a means to build critical mass is still very much in the cards in the U.K. biotech sector. Vanguard Medica Group plc and CeNeS Pharmaceuticals plc - two companies that started life with very different strategies - last week confirmed that they

Read the full 444 word article

How to gain access

Continue reading with a
two-week free trial.